New York, NY, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Brain Tumor Diagnosis and Treatment Market by Product (Primary Brain Tumor and Secondary Brain Tumor), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testing, EEG, and Others), and by Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, and Immunotherapy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024”. According to the report, the global brain tumor diagnosis and treatment market was valued at approximately USD 426 million in 2017 and is expected to generate revenue of around USD 744 million by the end of 2024, growing at a CAGR of around 8.65% between 2018 and 2024.
Brain tumors generally occur in supportive brain tissues. The exact cause of brain tumor is not yet known, and it can occur in any age group. Neurologists base the brain tumor treatment on the type, tumor location, tumor size, patient’s health, and patient’s age. The main drivers that fuel the growth of brain tumor diagnosis and treatment market are an increase in the occurrences of brain tumor, the rise in the geriatric population, and the development of technologies for tumor treatment.
Browse through 72 Tables & 30 Figures spread over 110 Pages and in-depth TOC on “Global Brain Tumor Diagnosis and Treatment Market: Industry Type, Size, Share, Trends and Forecast, 2017 – 2024”.
Request Free Sample Report of Global Brain Tumor Diagnosis and Treatment Market Report @ https://www.zionmarketresearch.com/sample/brain-tumor-diagnosis-and-treatment-market
The brain tumor diagnosis and treatment market are segmented based on product, diagnosis type, and treatment type. The product segment of this market includes primary brain tumor and secondary brain tumor. Primary brain tumors are sub-divided into gliomas, meningioma, pituitary tumors, astrocytomas, and other primary brain tumors. In 2016, the primary brain tumor held approximately 74% of the total product type segment of brain tumor diagnosis and treatment market. The rise in brain tumor incidences and CNS-related cancers in regions like Europe and the Asia Pacific is mainly going to fuel the primary brain tumor segment globally.
Based on diagnosis type, this market is classified into PET-CT scan, MRI, CT scan, EEG, molecular testing, and others. The CT scan segment is anticipated to lead this market. The 3D images obtained through CT scan are captured from all angles and the ability of CT scan to differentiate between soft tissues and bone masses is fueling the growth for the demand for CT scan for diagnosing brain tumors.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/brain-tumor-diagnosis-and-treatment-market
The treatment type segment of brain tumor diagnosis and treatment market includes chemotherapy, radiation therapy, targeted therapy, surgery, and immunotherapy. The surgery segment is expected to dominate this market. The availability of limited treatment options for the treatment of grade IV and low awareness levels about other treatment options are expected to fuel the demand for surgery segment.
North America is projected to dominate the brain tumor diagnosis and treatment market in the forecast timeframe. In 2017, it held over 43% of the global market for brain tumor diagnosis and treatment. The U.S. held approximately 88% of the total North American brain tumor diagnosis and treatment market in the year 2016. According to the National Brain Tumor Society, in 2015, approximately 7 lakh people in America were suffering from brain tumors and it was estimated that 78,000 people will suffer from it in 2016. This rapid increase in the population suffering from brain tumors is anticipated to drive the brain tumor diagnosis and treatment market. The growing research related to the technological developments to treat brain tumor and increasing awareness about treatments and management of brain tumors among the population is anticipated to fuel the expansion of this market in North America.
Request for The Discount: https://www.zionmarketresearch.com/requestdiscount/brain-tumor-diagnosis-and-treatment-market
Europe is projected to show the best growth rate in the forecast timeframe, owing to increasing brain tumor cases and growing government initiatives. The rise in the number of patients suffering from malignant cancer is also fueling the expansion of brain tumor diagnosis and treatment market. In 2016, Eurostat stated that about 20% of the total European population was above 65 years old. This population is generally vulnerable and is likely to suffer from brain tumors. Increase in the percentage of people above 65 years is anticipated to fuel the development of brain tumor diagnosis and treatment market in the European region.
The Asia Pacific region is anticipated to show rapid growth in the forecast timeframe. The increase in the prevalence of brain tumors, the introduction of various technologies and therapies, and the rising awareness regarding the diagnosis and treatment techniques are some factors fueling the demand for brain tumor diagnosis and treatment market in this region. The presence of emerging economies and growing investments made in the healthcare sector are also contributing to the development of brain tumor diagnosis and treatment market in this region.
Browse the full "Brain Tumor Diagnosis and Treatment Market: by Product (Primary Brain Tumor and Secondary Brain Tumor), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testing, EEG, and Others), and by Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, and Immunotherapy) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024"report at https://www.zionmarketresearch.com/report/brain-tumor-diagnosis-and-treatment-market
The Middle East and Africa and Latin America are projected to show slow growth in the forecast timeframe. Rising metastatic tumor occurrences, development of drug delivery technologies, and increased use of the combination of modern techniques for its diagnosis are some factors fueling the growth of this market in these regions.
The main players of the global brain tumor diagnosis and treatment market are AstraZeneca, GE Healthcare, Carestream Health, Pfizer, Inc., Merck & Co. Inc., Siemens Healthineers, Hitachi Medical Corporation, Philips Healthcare, Toshiba Medical Systems Corporation, and Shimadzu Corporation. These companies focus on mergers and collaborations to develop their diagnostics techniques. For instance, in 2015, NICO announced its collaboration with Hitachi Aloka Medical to improve visualization of difficult to reach brain tumors.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/brain-tumor-diagnosis-and-treatment-market
This report segments the global brain tumor diagnosis and treatment market as follows:
Global Brain Tumor Diagnosis and Treatment Market: Product Segment Analysis
- Primary Brain Tumor
- Meningioma
- Gliomas
- Astrocytomas
- Pituitary Tumors
- Other Primary Brain Tumors
- Secondary Brain Tumor
Global Brain Tumor Diagnosis and Treatment Market: Diagnosis Type Segment Analysis
- CT Scan
- MRI
- PET-CT Scan
- Molecular Testing
- EEG
- Others
Global Brain Tumor Diagnosis and Treatment Market: Treatment Type Segment Analysis
- Surgery
- Radiation Therapy
- Targeted Therapy
- Chemotherapy
- Immunotherapy
Global Brain Tumor Diagnosis and Treatment Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Homeopathy Products Market: https://www.zionmarketresearch.com/report/homeopathy-products-market
- U.S. Healthcare Transportation Services Market: https://www.zionmarketresearch.com/report/the-us-healthcare-transportation-services-market
- Peptide Therapeutics Market: https://www.zionmarketresearch.com/report/peptide-therapeutics-market
- Cognitive and Memory Enhancer Drugs Market: https://www.zionmarketresearch.com/report/cognitive-and-memory-enhancer-drugs-market
- Connected Healthcare Market: https://www.zionmarketresearch.com/report/connected-healthcare-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com